
Overview
Pube Global exports and imports pharmaceutical products, sourcing and registering medicines for Ukraine and EU markets. It supplies generic and essential medicines, biologicals, biotech products, OTC products, nutraceuticals, and medical devices, and provides regulatory support, logistics, and distribution.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $26,683 |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 306 days for 2020).
- 202503/06/2026
- 202427/05/2025
- 202330/06/2024
- 202225/05/2023
- 202120/12/2022
- 202017/08/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Generic medicines
- Biologic medicines
- Vaccines
- Over-the-counter medicines
- Dietary supplements
- Medical devices
- Medicine registration
- Medicine distribution
Websites
The site is available in: Polish and English.
- pubeglobal.comPharmaceutical Export & Import to Ukraine, Poland & EU | PUBE GLOBALGoogle Tag Manager
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations and sign documents on behalf of the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Nataliia Ebeid age 48 | 18,200 | $245,813.07 | 91% |
Others | 1,800 | $24,311.18 | 9% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-07-27.
10 1020 4900 0000 8102 3680 0899
89 1020 4900 0000 8602 3680 0978
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 659.6KPLN 659,615 |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Inpharm sp. z o.o. + limited partnership | $6,617,533.89 | inpharm.pl | ||
| Noris Polska sp. z o.o. | $4,417,954.24 | norispolska.pl | ||
| Ekspres Apteczny sp. z o.o. | $2,671,602.33 | ekspresapteczny.pl | ||
| GWS Poland sp. z o.o. | $2,706,990.11 | gwspoland.pl | ||
| Senju Poland sp. z o.o. | $1,921,300.71 | senjupoland.pl | ||
| Travel Care sp. z o.o. | $1,744,417.39 | travelcare.pl | ||
| Nutralic sp. z o.o. | $1,597,591.01 | nutralic.pl | ||
| Alpen Pharma Polska sp. z o.o. | $1,465,675.63 | alpenpharma.pl | ||
| Norameda Polska sp. z o.o. | $1,352,431.19 | norameda.com | ||
| Madamar sp. z o.o. | $1,041,108.65 | madamar.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-20 | Address change (Ul. Jana Pawła II 27, 00-867, Warszawa → Aleja Jana Pawła II 27, 00-867, Warszawa) | |
| 2026-05-04 | Share capital increase (5,000.00 PLN → 1,000,000.00 PLN) | |
| 2025-07-25 | Switch to PKD 2025 (9 PKD 2007 codes → 7 PKD 2025 codes) | |
| 2020-05-29 | Address change (Ul. Łąkowa 9/46, 15-017, Białystok → Ul. Jana Pawła II 27, 00-867, Warszawa) | |
| 2015-12-09 | Entered in the register |
FAQ
Last updated: 2026-10-20